Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023473 (
chronic myeloid leukemia
)
18,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A patient whose leukaemic cells carried the rare t(7;11)(p15;p15) was diagnosed as having acute myelomonocytic leukaemia (AML-M4), and supports the association of this specific translocation with forms of acute myeloid leukaemia showing differentiation. Blast phase
chronic myeloid leukaemia
was excluded by lack of involvement of the ABL and BCR genes. Chromosome in situ hybridization studies showed that both the
HRAS1
and INS genes were present on the terminal part of chromosome 11p which was translocated to chromosome 7p. Neither
HRAS1
nor INS were structurally rearranged. Field inversion gel electrophoresis showed that a 400 kb fragment encompassing
HRAS1
was structurally entire in leukaemic DNA. Because the INS gene, which was also translocated, is probably located proximal to
HRAS1
on chromosome 11p, it is unlikely that
HRAS1
was near the chromosome 11 breakpoint or involved in this leukaemia.
...
PMID:HRAS1 and INS genes are relocated but not structurally altered as a result of the t(7;11)(p15;p15) in a clone from a patient with acute myeloid leukaemia (M4). 271 71